5-151316979-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_181776.3(SLC36A2):c.1290G>A(p.Thr430Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.561 in 1,613,262 control chromosomes in the GnomAD database, including 259,998 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.58 ( 26129 hom., cov: 30)
Exomes 𝑓: 0.56 ( 233869 hom. )
Consequence
SLC36A2
NM_181776.3 synonymous
NM_181776.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.98
Genes affected
SLC36A2 (HGNC:18762): (solute carrier family 36 member 2) This gene encodes a pH-dependent proton-coupled amino acid transporter that belongs to the amino acid auxin permease 1 protein family. The encoded protein primarily transports small amino acids such as glycine, alanine and proline. Mutations in this gene are associated with iminoglycinuria and hyperglycinuria. [provided by RefSeq, Sep 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.22).
BP6
Variant 5-151316979-C-T is Benign according to our data. Variant chr5-151316979-C-T is described in ClinVar as [Benign]. Clinvar id is 1245781.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-151316979-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=1.98 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.828 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC36A2 | NM_181776.3 | c.1290G>A | p.Thr430Thr | synonymous_variant | 10/10 | ENST00000335244.9 | NP_861441.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC36A2 | ENST00000335244.9 | c.1290G>A | p.Thr430Thr | synonymous_variant | 10/10 | 1 | NM_181776.3 | ENSP00000334223.4 |
Frequencies
GnomAD3 genomes AF: 0.581 AC: 88055AN: 151630Hom.: 26110 Cov.: 30
GnomAD3 genomes
AF:
AC:
88055
AN:
151630
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.619 AC: 155136AN: 250826Hom.: 49784 AF XY: 0.615 AC XY: 83343AN XY: 135560
GnomAD3 exomes
AF:
AC:
155136
AN:
250826
Hom.:
AF XY:
AC XY:
83343
AN XY:
135560
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.559 AC: 816865AN: 1461514Hom.: 233869 Cov.: 79 AF XY: 0.563 AC XY: 408981AN XY: 727034
GnomAD4 exome
AF:
AC:
816865
AN:
1461514
Hom.:
Cov.:
79
AF XY:
AC XY:
408981
AN XY:
727034
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.581 AC: 88128AN: 151748Hom.: 26129 Cov.: 30 AF XY: 0.585 AC XY: 43374AN XY: 74122
GnomAD4 genome
AF:
AC:
88128
AN:
151748
Hom.:
Cov.:
30
AF XY:
AC XY:
43374
AN XY:
74122
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2664
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Hyperglycinuria Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at